CAS 100286-90-6
:Irinotecan hydrochloride
Description:
Irinotecan hydrochloride is a semi-synthetic derivative of camptothecin, primarily used as a chemotherapeutic agent in the treatment of various cancers, particularly colorectal cancer. It functions as a topoisomerase I inhibitor, interfering with DNA replication and transcription, which ultimately leads to cancer cell death. The compound is typically administered intravenously and is known for its effectiveness in combination therapies. Irinotecan hydrochloride is characterized by its solubility in water, which facilitates its formulation for clinical use. The substance has a complex molecular structure, featuring a lactone ring that is crucial for its pharmacological activity. Common side effects associated with irinotecan include diarrhea, nausea, and myelosuppression, necessitating careful monitoring during treatment. Its pharmacokinetics involve metabolism primarily by the liver, with active metabolites contributing to its therapeutic effects and toxicity. Overall, irinotecan hydrochloride represents a significant advancement in cancer therapy, offering a targeted approach to treatment while highlighting the importance of managing its side effects.
Formula:C33H39ClN4O6
InChI:InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
InChI key:InChIKey=GURKHSYORGJETM-WAQYZQTGSA-N
SMILES:C(C)C1=C2C(C=3N(C2)C(=O)C4=C(C3)[C@](CC)(O)C(=O)OC4)=NC=5C1=CC(OC(=O)N6CCC(CC6)N7CCCCC7)=CC5.Cl
Synonyms:- (19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0[2,11].0[4,9].0[15,20]]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate hydrochloride
- (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate
- (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride (1:1)
- (4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride trihydrate
- (S)-4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester
- (S)-[1,4'-Bipiperidine]-1'-Carboxylic Acid, 4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester Hydrochloride
- 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline, [1,4′-bipiperidine]-1′-carboxylic acid deriv.
- 7-Ethyl-10-[[4-(1-piperidyl)-1-piperidyl]carbonyloxy]camptothecin hydrochloride
- Campto
- Camptosar
- Camptothecin 11
- Camptothecin 11 hydrochloride
- Cpt 11
- Irinotecan, Hydrochloride
- Topotecin
- Topotecin Hydrochloride
- Topotesin
- U 101440E
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride (1:1)
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride
- [1,4′-Bipiperidine]-1′-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride, (S)-
- [1,4'-BIPIPERIDINE]-1'-CARBOXYLIC ACID
- CAMPTOTHECIN 11 HYDROCHLORIDE,TOPOTECIN
- IRINOTECAN HCL
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride, (S)-
- (s)-ydrochlorid
- 7-ethyl-10-(4-(1-piperidino)-1-piperidino)carbonyloxycamptothecinhydrochlor
- (1,4’-bipiperidine)-1’-carboxylicacid,3,4,12,14-tetrahydro-4,11-diethyl-4-hyd
- roxy-3,4-dioxo-1h-pyrano(3’,4’:6,7)indolizino(1,2-b)quinolin-9-ylester,monoh
- u10144oe
- [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride (9CI)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
Irinotecan Hydrochloride Trihydrate
CAS:Formula:C33H38N4O6·HCl·3H2OPurity:>98.0%(T)(HPLC)Color and Shape:White to Orange to Green powder to crystalMolecular weight:677.20Irinotecan hydrochloride
CAS:<p>Topoisomerase I inhibitor</p>Formula:C33H38N4O6•HClMolecular weight:623.14[1,4'-Bipiperidine]-1'-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride
CAS:Formula:C33H39ClN4O6Purity:98%Color and Shape:SolidMolecular weight:623.1390Irinotecan Hydrochloride
CAS:<p>Irinotecan HCl, a camptothecin derivative prodrug, becomes active metabolite SN-38, inhibiting topoisomerase I to trigger apoptosis.</p>Formula:C33H39ClN4O6Purity:98% - 99.94%Color and Shape:Yellow Crystalline PowderMolecular weight:623.14Irinotecan hydrochloride anhydrous
CAS:<p>Inhibitor of DNA topoisomerase I</p>Formula:C33H38N4O6·HClPurity:Min. 95%Color and Shape:Off-White PowderMolecular weight:623.14 g/molIrinotecan, Hydrochloride Salt
CAS:Formula:C33H39ClN4O6Purity:98.0%Color and Shape:SolidMolecular weight:623.15









